# FDA 483 - DPT Laboratories Ltd - February 10, 2026

Source: https://www.keypedia.com/records/483/dpt-laboratories-ltd/ff9dfd32-2420-46ad-9a54-0230a46f93f3

> FDA 483 for DPT Laboratories Ltd on February 10, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: DPT Laboratories Ltd
- Inspection Date: 2026-02-10
- Product Type: drugs
- Office Name: Dallas District Office
- Summary: DPT Laboratories Ltd, a drug product manufacturer in San Antonio, TX, was cited for significant deficiencies in its manufacturing process controls and validation, particularly concerning the leak detection process for aerosol drug products. The firm failed to adequately validate its packaging controls and maintain consistent routine production practices, leading to concerns about container-closure integrity and product quality. Additionally, the company lacked adequate written procedures and objective criteria in its SOPs and master batch records for visual inspection and leak detection.

## Related Documents

- [483 - 2014-05-01](https://www.keypedia.com/records/483/dpt-laboratories-ltd/9641550e-2386-44d6-bb5a-2bd00a8253a8)
- [483 - 2016-08-26](https://www.keypedia.com/records/483/dpt-laboratories-ltd/f67ece43-e746-4ffa-bb96-11848fd555b5)
- [483 - Unknown Date](https://www.keypedia.com/records/483/dpt-laboratories-ltd/4615a92b-b5f4-4201-8b6b-9e4359c38523)
- [483 - 2026-02-10](https://www.keypedia.com/records/483/dpt-laboratories-ltd/acfe4a99-4fb6-4a44-9375-b19c5230dd9c)

## Related Officers

- [Investigator](https://www.keypedia.com/people/shanna-n-purdy/7a677cf5-484f-4e9a-91b1-27398411ff32)

Company: https://www.keypedia.com/companies/dpt-laboratories-ltd/b2d45aa5-6cf4-4401-87a2-35470321dc30

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9